The legacy success of sildenafil has undeniably shaped the healthcare landscape. However, putting money in companies heavily dependent on generic versions and the diminishing patent protection surrounding https://bookmark-media.com/story21510207/sildenafil-and-drugmakers-a-risky-opportunity